Stock Analiz

A vs BIO stock comparison

Agilent Technologies vs. Bio-rad Laboratories · data as of November 13, 2026

Agilent Technologies (A) has a market value of about $49.0B, Bio-rad Laboratories (BIO) about $9.9B. Over their latest twelve months Agilent Technologies had revenue of $7.4B and Bio-rad Laboratories $2.6B.

On our five checks Agilent Technologies scores higher: 2.6 out of 5 (average) against 2.2 (weak).

By area, the stronger company is Bio-rad Laboratories on value; Bio-rad Laboratories on future growth; Agilent Technologies on track record; Agilent Technologies on shareholder returns.

Bio-rad Laboratories is cheaper on earnings (P/E 9.7 vs. 34.3), while Agilent Technologies grew revenue faster over five years (5.4% vs. 0.3% a year).

Agilent Technologies leads on 14 of the compared lines and Bio-rad Laboratories on 9.

Side by side

ABIO
Size and price
Market cap$49.0B$9.9B
Share price$173.96$366.36
Score
Overall score (of 5)2.62.2
Value02
Future growth13
Track record40
Financial health33
Shareholder returns53
Valuation
P/E (TTM)34.39.7
Forward P/E26.434.5
Price / free cash flow38.729.9
Price / sales6.73.8
EV / EBITDA26.892.3
PEG2.33—
DCF value vs. price−42%−62%
Business
Revenue$7.4B$2.6B
Net income$1.4B$1.0B
Free cash flow$1.3B$329M
Net margin19.5%39.5%
Gross margin (5-yr avg.)53.1%54.2%
ROIC (5-yr avg.)14.4%2.4%
Growth
Revenue growth (1 yr)6.7%0.7%
Revenue growth (5 yrs, per year)5.4%0.3%
EPS growth (5 yrs, per year)14.7%-26.1%
Balance sheet and payouts
Net cash (cash minus debt)-$2.1B$301M
Dividend yield0.59%None
Shareholder yield1.5%3.0%
Analysts
Upside to average target+5%−3%
Consensus ratingBuyHold

Highlighted = the better figure on that line. Revenue, net income and free cash flow: A TTM to July 31, 2026, BIO TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Agilent Technologies or Bio-rad Laboratories?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Agilent Technologies scores 2.6 out of 5 and Bio-rad Laboratories 2.2; the table shows where each one is stronger.

Is Agilent Technologies cheaper than Bio-rad Laboratories?

On trailing earnings, Bio-rad Laboratories trades at a P/E of 9.7 and Agilent Technologies at 34.3, so Bio-rad Laboratories is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Agilent Technologies or Bio-rad Laboratories?

Over five years Agilent Technologies grew revenue about 5.4% a year and Bio-rad Laboratories about 0.3% a year.

Which pays a higher dividend?

Agilent Technologies yields 0.59% and Bio-rad Laboratories nothing (no dividend).

Full Agilent Technologies analysis → Full Bio-rad Laboratories analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.